Detalles de la búsqueda
1.
The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome.
Gastroenterology
; 141(2): 507-16, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21684281
2.
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide.
Endocr Relat Cancer
; 21(5): 705-14, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25012985
3.
Effects of LX4211, a dual SGLT1/SGLT2 inhibitor, plus sitagliptin on postprandial active GLP-1 and glycemic control in type 2 diabetes.
Clin Ther
; 35(3): 273-285.e7, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23433601
4.
Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects.
Clin Ther
; 35(8): 1162-1173.e8, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23911260
5.
Study design and rationale of a dose-ranging trial of LX4211, a dual inhibitor of SGLT1 and SGLT2, in type 2 diabetes inadequately controlled on metformin monotherapy.
Clin Cardiol
; 36(7): 367-71, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23630033
Resultados
1 -
5
de 5
1
Próxima >
>>